Brain Cancer

Cerebral Glioblastoma

Male, 48 years

Patient Internal 500182761

ICD-10 code

C71.8 Malignant Neoplasm of Overlapping Sites of Brain

Diagnosis (Incl. Metastases/Stage) and Year

May 2021
Cerebral Glioblastoma G4, IDH (-), TERT (+), Monosomy of Chromosome 10, EGFR1 amplification, MGMT (+), Ki67 – 20%. The patient is Post-Craniotomy with disease recurrence after 1 month.

Previous Treatment

Surgery, Radiation Therapy, Chemotherapy (Temozolomide and Lomustin)

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of 14 months from diagnosis.

Treatment Provided

Autologous DCV (8 doses) and CIK (4 doses) over a period of 10 months.

Patient Survival/Condition and Year
Date of Review: 15/10/2023

The patient has lived for 23 months after the diagnosis. It can be concluded that the addition of Immunotherapy, alongside Surgery, Chemotherapy and Radiation Therapy, has extended the patient’s survival by about 9 months from median survival.